Sun Pharmaceutical Industries Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
363835.15 Cr.
|
P/BV
|
6.50
|
Book Value (Rs.)
|
233.38
|
52 Week High/Low (Rs.)
|
1639/922
|
FV/ML
|
1/1
|
P/E(X)
|
42.94
|
Bookclosure
|
09/02/2024
|
EPS (Rs.)
|
35.32
|
Div Yield (%)
|
0.76
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 35.30 | 13.60 | 12.10 | 15.70 | 11.10 |
Diluted EPS (Rs.) | 35.30 | 13.60 | 12.10 | 15.70 | 11.10 |
Cash EPS (Rs.) | 46.22 | 23.13 | 18.19 | 26.01 | 20.68 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 247.22 | 212.84 | 206.23 | 204.75 | 186.40 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 247.22 | 212.84 | 206.23 | 204.75 | 186.40 |
Revenue From Operations / Share (Rs.) | 182.91 | 161.11 | 139.62 | 136.86 | 121.14 |
PBDIT / Share (Rs.) | 51.19 | 47.18 | 38.87 | 31.78 | 30.56 |
PBIT / Share (Rs.) | 40.64 | 38.24 | 30.20 | 23.23 | 23.26 |
PBT / Share (Rs.) | 39.21 | 18.68 | 11.67 | 20.88 | 15.88 |
Net Profit / Share (Rs.) | 35.68 | 14.20 | 9.52 | 17.45 | 13.38 |
NP After MI And SOA / Share (Rs.) | 35.32 | 13.64 | 12.10 | 15.69 | 11.11 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 27.98 | 29.28 | 27.84 | 23.22 | 25.22 |
PBIT Margin (%) | 22.22 | 23.73 | 21.63 | 16.97 | 19.19 |
PBT Margin (%) | 21.43 | 11.59 | 8.35 | 15.25 | 13.10 |
Net Profit Margin (%) | 19.50 | 8.81 | 6.82 | 12.75 | 11.04 |
NP After MI And SOA Margin (%) | 19.30 | 8.46 | 8.66 | 11.46 | 9.17 |
Return on Networth / Equity (%) | 15.13 | 6.81 | 6.24 | 8.31 | 6.43 |
Return on Capital Employeed (%) | 16.02 | 17.44 | 14.06 | 10.60 | 11.78 |
Return On Assets (%) | 10.49 | 4.68 | 4.29 | 5.51 | 4.12 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.04 | 0.03 |
Total Debt / Equity (X) | 0.11 | 0.01 | 0.07 | 0.16 | 0.23 |
Asset Turnover Ratio (%) | 0.58 | 0.56 | 0.23 | 0.24 | 0.20 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 2.00 | 2.04 | 1.89 | 2.02 | 1.79 |
Quick Ratio (X) | 1.48 | 1.51 | 1.33 | 1.51 | 1.34 |
Inventory Turnover Ratio (X) | 0.79 | 0.78 | 0.69 | 0.60 | 0.56 |
Dividend Payout Ratio (NP) (%) | 29.73 | 65.96 | 53.68 | 36.62 | 17.97 |
Dividend Payout Ratio (CP) (%) | 22.89 | 39.85 | 31.28 | 23.70 | 10.84 |
Earning Retention Ratio (%) | 70.27 | 34.04 | 46.32 | 63.38 | 82.03 |
Cash Earning Retention Ratio (%) | 77.11 | 60.15 | 68.72 | 76.30 | 89.16 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 71.40 | 88.88 | 65.95 | 25.19 | 13.21 |
Interest Coverage Ratio (Post Tax) (%) | 51.77 | 63.60 | 47.60 | 15.69 | 8.97 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 239622.86 | 218440.19 | 143296.74 | 89454.34 | 120917.76 |
EV / Net Operating Revenue (X) | 5.46 | 5.65 | 4.28 | 2.72 | 4.16 |
EV / EBITDA (X) | 19.51 | 19.30 | 15.36 | 11.73 | 16.49 |
MarketCap / Net Operating Revenue (X) | 5.37 | 5.68 | 4.28 | 2.57 | 3.96 |
Retention Ratios (%) | 70.26 | 34.03 | 46.31 | 63.37 | 82.02 |
Price / BV (X) | 4.21 | 4.57 | 3.09 | 1.87 | 2.78 |
Price / Net Operating Revenue (X) | 5.37 | 5.68 | 4.28 | 2.57 | 3.96 |
EarningsYield | 0.03 | 0.01 | 0.02 | 0.04 | 0.02 |